Press releases
These press releases are intended for journalists and analysts/investors.
-
Fluarix® Product Notification
GlaxoSmithKline Australia (GSK) in consultation with the Therapeutic Goods Administration (TGA) has issued a product notification
Read more -
GSK’s response to the public roundtable report on Arachnoiditis
GlaxoSmithKline (GSK) has reviewed the final report of the House of Representatives Standing Committee on Health and Ageing
Read more -
Report on the Public roundtable into Adhesive Arachnoiditis
GlaxoSmithKline (GSK) welcomes the report on the roundtable into adhesive arachnoiditis provided by the Standing Committee
Read more -
GSK Australia divestment of Kapanol Complete
GSK Australia’s divestment of the pain relief product Kapanol (morphine sulphate) to Mayne Pharma Group Limited (Mayne Pharma)
Read more
-
About us
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
-
Products
We make a wide range of prescription medicines, vaccines and consumer healthcare products.
-
Careers
GSK is a place where talented people do amazing things. Where you are encouraged to be you and create a meaningful impact.
-
Research and development
Science can improve health and well-being in so many ways, from the development of everyday convenience healthcare products.
